Atlas Trials

RET Inhibitor for Neoadjuvant Therapy in Locally Advanced RET-altered Thyroid Cancer

Clinical trial NCT06530316 · RECRUITING

Trial details

NCT number
NCT06530316
Sponsor
Fudan University
Status
RECRUITING
Study type
OBSERVATIONAL
Thyroid Cancer
Start date
2024-07-18
Primary completion
2026-12-31
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.